Rigel Pharmaceuticals Inc (RIGL) — Cash Flow Reinvestment Rate
Rigel Pharmaceuticals Inc (RIGL) has a Cash Flow Reinvestment Rate of 2.86x as of June 2026, reinvesting $87.80 Million (capex $0.00 plus investments $87.80 Million) from operating cash flow of $30.65 Million. See RIGL free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Rigel Pharmaceuticals Inc Cash Flow Reinvestment Rate (2010–2025)
Historical reinvestment intensity for Rigel Pharmaceuticals Inc across 4 annual periods. For the full cash flow conversion analysis, see Rigel Pharmaceuticals Inc (RIGL) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Rigel Pharmaceuticals Inc (2010–2025)
Year-by-year capital reinvestment analysis for Rigel Pharmaceuticals Inc. See Rigel Pharmaceuticals Inc (RIGL) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.22x | $92.36 Million | $75.66 Million | $0.00 | ▲ +748.9% |
| 2024 | 0.14x | $4.53 Million | $31.47 Million | $396.00K | ▼ -98.9% |
| 2021 | 13.62x | $80.04 Million | $5.88 Million | $627.00K | ▲ +17778.1% |
| 2010 | 0.08x | $3.56 Million | $46.74 Million | $3.56 Million | — |